Ranibizumab: prices and alternatives
Indicated for neovascular age-related macular degeneration, macular edema following retinal vein occlusion, and myopic choroidal neovascularization.
2 products with this active ingredient from 1 manufacturer. Official prices from 5600 to 8167 EGP.
Every box with this active ingredient, cheapest first.
Informational only — may be inaccurate or incomplete. Don't rely on it medically; verify with a pharmacist.

